T hree main cell death phenotypes have been identified in mammalian systems: apoptosis, autophagy and programmed necrosis. Currently, the field lacks systems level approaches to assess how the intricate crosstalk and interconnectivity between the different death functional modules affect the cell's final outcome. In order to dissect the cell death network's architecture, we developed a platform that measures the outcome of single and double RNAi-mediated perturbations of different apoptotic and autophagic genes on both the final cell death performance, and the pattern of protein connectivity. We applied this platform on cells exposed to a DNA damaging drug, and identified several levels of connectivity between apoptosis and autophagy. In addition, using computational methods we suggested a novel biochemical pathway providing a connection between ATG5 and caspase-3. Scaling up this platform into hundreds of perturbations will reveal novel principles of the organization of the cell death network, and will provide the basis for future computational modeling.
T hree main cell death phenotypes have been identified in mammalian systems: apoptosis, autophagy and programmed necrosis. Currently, the field lacks systems level approaches to assess how the intricate crosstalk and interconnectivity between the different death functional modules affect the cell's final outcome. In order to dissect the cell death network's architecture, we developed a platform that measures the outcome of single and double RNAi-mediated perturbations of different apoptotic and autophagic genes on both the final cell death performance, and the pattern of protein connectivity. We applied this platform on cells exposed to a DNA damaging drug, and identified several levels of connectivity between apoptosis and autophagy. In addition, using computational methods we suggested a novel biochemical pathway providing a connection between ATG5 and caspase-3. Scaling up this platform into hundreds of perturbations will reveal novel principles of the organization of the cell death network, and will provide the basis for future computational modeling.
Programmed cell death (PCD) is turned on by well-defined input signals, and is driven by a network of ∼150 proteins that are connected to each other in an intricate manner. One of the challenges in the field is to study the functional connectivity among the cell death proteins that constitute three main modules (apoptosis, autophagy and programmed necrosis), and assess how this connectivity determines the cell death outcome (Fig 1A) . We chose to study the properties of this complex
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A systems level strategy for analyzing the cell death network Einat Zalckvar, Shani Bialik and Adi Kimchi* Department of Molecular Genetics; Weizmann Institute of Science; Rehovot, Israel system by assessing the outcome of knocking down individual proteins, singly and in combination, by RNAi, and determining the outcome of these perturbations on the final cell death performance.
We applied this approach to study the integration of the various modules of the cell death network in response to the DNA-damaging agent etoposide, which activates a mixed death response involving apoptosis and programmed necrosis (Fig. 1B) . The power of this approach stemmed from three unique steps of the analysis. First, cell death performance was measured independently of the type of cell death predominating in the system, by assessing cell viability based on the activity of a stably expressed luciferase reporter gene in HEK293 cells. This unbiased assay enabled accurate and sensitive quantification of the population's response to etoposide treatment, over a wide linear range. When applied to perturbed cells, in which critical proteins of the apoptotic and autophagic modules were knocked down, it provided the means of measuring the functional weight of nodes with even minor contributions to the overall output, and of calculating the fitness values of the genetic interactions between pairs of apoptotic and autophagic genes. Second, the perturbations' effects on the molecular responses to the cell death agent, not only downstream to the knocked-down gene but also within distant functional modules, were assessed by biochemical and microscopy analysis of molecular markers of the different death modules. Finally, computational methods were utilized for the discovery of pathways mediating the newly identified genetic interactions by autophagic and apoptotic proteins. For example, although the autophagy module is dormant when apoptosis is intact, the single perturbation of ATG5 partially reduces apoptosis, implying that ATG5 is connected to the apoptotic module independent of its canonical role in autophagy. As we did not detect the presence of cleaved ATG5 in this setting, we assumed that the connectivity of ATG5 to apoptosis differs from previously described mechanisms. In order to elucidate the molecular connection between ATG5 and caspase-3, we employed computational tools for mining human PPI databases, and for the simultaneous depletion of caspase-3 and beclin 1 or ATG5, reduces the cell death performance. Thus, in this setting, autophagy provides an alternative backup mechanism of cell death called into action upon caspase-3 perturbation. The calculated fitness value of the double Beclin 1 and caspase-3 perturbations correspond to an aggravating type of interaction, consistent with the backup model. This intermodular switch provides one explanation for the robustness of the PCD system to single perturbations.
A second important finding is the surprising connectivity between individual mining protein-protein interaction (PPI) databases.
A major principle that emerged from the initial study of a small number of perturbations is that system performance or robustness, can be maintained through activation of dormant death modules upon knock down of the alternate pathways. For example, whereas caspase-3 knockdown attenuates apoptosis, and surprisingly the programmed necrotic phenotype, it triggers the induction of autophagic markers, and does not affect overall cell death performance (Fig. 1C) . Targeting both apoptotic and autophagic modules, through Figure 1 . the pcD maze. (A) A mammalian cell has three main programmed ways to die: apoptosis (green road), programmed necrosis (yellow road) and autophagy (purple road). the latter represents an interesting dichotomy in which the canonical prosurvival effects of autophagy can, under certain circumstances, be transformed into death pathways. it is still not known what the molecular mechanisms are that govern the choice of death module activated in response to a given intrinsic trigger, and why one cell death scenario predominates in a specific circumstance/cell type. Accumulating data suggest that in some cellular settings and death scenarios a mixed phenotype of more than one type of death can be activated within a single cell. (B) under basal conditions, etoposide activated the apoptosis and necrosis modules in hEK293-Luciferase cells, leading to cell death, defined as full cell death performance. (c) When caspase-3 was knocked-down (KD), apoptosis and surprisingly also necrosis were blocked, but autophagy was activated. Full cell death performance was maintained. note that this scheme is oversimplified. Questions such as how the switch to autophagy occurs, and why autophagy is a pro-death pathway under etoposide treatment and caspase-3 perturbation should be further studied.
calculating the most reliable molecular pathways underlying this link. Public databases and published interaction data were culled to generate a PPI database of ∼40,000 interactions connecting ∼10,000 proteins. Confidence values were assigned to all protein interactions (edges), based on the amount of supporting experimental evidence, and to the cell death proteins (nodes), reflecting their functional relatedness to the PCD set. In addition, the defined set of PCD proteins was further refined by adding manually curated interactions and assigning directionality to the existing edges. The most reliable pathway displaying the highest overall confidence is predicted to link ATG5 to caspase-3 through the molecular scaffold rhophilin2, cytokeratin-18, and the death effector domain-containing DNAbinding protein, DEDD. Experimental validations subsequently confirmed the validity of this proposed pathway.
Altogether, our strategy has revealed several network principles, including inter-modular crosstalk, and delineation of new molecular connectivities that define novel pathways. It serves as a proof-of-principle as to the feasibility of the approach to large-scale network analysis, and should be scaled up to yield more principles on the functional organization of the complex PCD network. This can be done by using a wider range of single and double perturbations, additional cell lines (i.e., different cellular contexts) and various death triggers. This will provide the tools to address many unresolved questions in the cell death field. For example, why does one cell death pathway predominate in a specific circumstance/cell type and what are the molecular mechanisms that govern this choice? How does the cell determine the final outcome when multiple death and/ or survival pathways are activated simultaneously or when some pathways are suppressed? This strategy has a wide, general scope of applicability, and will potentially provide the basis for future modeling of the cell death network.
